Design, synthesis, cytotoxic evaluation and molecular docking studies of novel thiazolyl α-aminophosphonates
作者:Mohan Gundluru、Vishnu Nayak Badavath、Haroon Yasmin Shaik、Murali Sudileti、Bakthavatchala Reddy Nemallapudi、Sravya Gundala、Grigory V. Zyryanov、Suresh Reddy Cirandur
DOI:10.1007/s11164-020-04321-6
日期:2021.3
screened for cytotoxic activity against human breast cancer (MCF-7 and MDA-MB-231), prostate cancer (DU-145) liver cancer (HepG2) and HeLa cancer cell lines using sulfarodamine-B (SRB assay). Compounds (8b, –4OMe), (8h, –4NO2) and (8j, –2I, –4CF3) showed better anticancer activity when compared with standard drug Adriamycin. Further in-silico target hunting reveals the anticancer activity of the designed
2-(3-甲酰基-4-异丁氧基苯基)-4-甲基噻唑-5-羧酸乙酯与各种芳基胺和亚磷酸二乙酯在溶剂-使用β-环糊精负载的磺酸(β-CD-SO3H)作为高效、可重复使用的非均相固体酸催化剂的自由条件。在较短的反应时间内以良好至优异的产率获得产物。使用磺胺胺-B(SRB 测定)筛选所有标题化合物对人乳腺癌(MCF-7 和 MDA-MB-231)、前列腺癌(DU-145)、肝癌(HepG2)和 HeLa 癌细胞系的细胞毒活性. 与标准药物阿霉素相比,化合物 (8b, –4OMe)、(8h, –4NO2) 和 (8j, –2I, –4CF3) 显示出更好的抗癌活性。